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ABSTRACT CD16b (FcRIIIb) is the most common receptor for the Fc domain of IgG on leukocytes. The binding of Fc
receptors to immunoglobulin triggers a wide array of immune responses. In published assays measuring the reaction of
CD16b with isotypes of soluble IgG, the affinity for IgG1 was low and that for IgG2 was undetectable. Here we report the first
measurement of kinetic rates of CD16b binding to membrane-bound IgG isotypes—a physically distinct and physiologically
more relevant presentation—using a recently developed micropipette method. In contrast to the soluble data, we found
clearly measurable IgG2 binding, with a forward kinetic rate six-fold lower than that of IgG1 but with an equilibrium affinity only
threefold lower. This suggests a nonnegligible role for IgG2 in Fc-mediated immune responses, particularly in longer duration
contacts. The binding constants were measured from two sets of experiments. Single-isotype experiments were analyzed by
an existing model (Chesla et al., 1998, Biophys. J. 75:1553–1572). The resulting kinetic rates were used as input to an
extended model (Zhu and Williams, 2000, Biophys. J. 79:1850–1857.) to predict the results of mixed-isotype experiments.
This design enabled rigorous validation of the concurrent binding model through a test of its predictive ability.
INTRODUCTION
Immunoglobulins (Ig), or antibodies, are central compo-
nents of the immune system. Of the five classes of human
antibodies, IgG is by far the most common, making up
about 80% of all antibodies in normal adult serum. IgG is
produced in four subclasses, or isotypes. IgG1, with a typ-
ical concentration of 6–9 mg/ml in plasma, makes up
about 60% of total IgG. IgG2 is normally present in serum
at 3–4 mg/ml or about 30% of total IgG. In contrast to
these dominant isotypes, IgG3 and IgG4 comprise, respec-
tively, only 6% and 3% of total IgG (Fridman, 1997).
Circulating IgG binds to foreign particles or damaged
tissue by direct recognition through dual, highly variable,
antigen binding fragments (Fab). The highly conserved Fc
fragment of this bifunctional molecule is available for bind-
ing by Fc receptors (FcRs) on the cell surface. Such an
interaction may trigger a cascade of effector functions that
may include cytokine release, immune complex clearance,
receptor-mediated phagocytosis, antibody-dependent cellu-
lar cytotoxicity, and enhancement of antigen presentation
(Selvaraj et al., 1989; Salmon et al., 1996; Rascu et al.,
1997; Clynes et al., 1998; Lowry et al., 1998). For this
reason, it is of great interest to characterize the IgG–FcR
interactions. Although it has been noted for some time that
the immune system responds to different pathogens with a
specific mix of IgG isotypes, very little is known about the
nature of their individual roles. With the exception of the
FcRIIaH131 allotype which binds IgG2 well (Warmerdam
et al., 1990; Clark et al., 1991; Rascu et al., 1997), affinity
measurements for soluble ligands have shown that FcRs
interact with human IgG1 and IgG3 much more readily than
with IgG2 or IgG4 (Huizinga et al., 1989; Powell et al.,
1996; Fridman, 1997; Rascu et al., 1997). In fact, in most
cases, any association between FcRs and these latter iso-
types was undetectable by the methods used. Nevertheless,
a clear correlation is seen between low IgG2 levels and
respiratory tract infections (Jefferis and Kumararatne,
1990).
Clues to the varied affinities of FcRs for each isotype
are seen in the quaternary structure of IgG. The most
striking structural differences between the isotypes lie in the
hinge region connecting Fab fragments with the Fc frag-
ment (Fig. 1). The hinge region of IgG1 includes two
disulfide bridges near the first Fc globular domains (C2).
Critical epitopes for FcR binding to all IgG isotypes ap-
pear on C2 (Burton, 1985). Rotational diffusion assays
have indicated that the IgG1 Fab fragments can flap as well
as rotate about their axes. This may give it an advantage in
both binding an antigen and providing FcRs access to the
critical C2 epitopes. IgG2 has a hinge region of similar
dimension as IgG1, but has two additional disulfide bridges
located near the base of the Fab fragments. This is likely to
greatly reduce flapping and may completely prevent axial
rotation of the Fab fragments.
The Fc receptors are a widely displayed family of cell
surface glycoproteins with varying affinity for the Fc frag-
ment of -chain-expressing Ig (IgG) (Fridman, 1989; Pow-
ell et al., 1996; Sautes, 1997). Of the three classes of FcRs
(FcRI, FcRII, and FcRIII or CD64, CD32, and CD16,
respectively) and various isoforms within each class (e.g.,
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CD16a and CD16b), FcRIIIb (CD16b) is unique in four
aspects: It is the predominant Fc receptor in blood; it is
exclusively expressed on granulocytes; it anchors to the cell
membrane by means of a glycosyl phosphatidylinositol
(GPI) moiety without transmembrane and cytoplasmic do-
mains; and it has no associated side chains (Selvaraj et al.,
1988; Sautes, 1997). Although a number of groups have
measured the affinity of Fc receptors to soluble Ig (Fridman,
1989; Huizinga et al., 1989; Powell et al., 1996; Rascu et al.,
1997), there have been no published reports outside of our
lab regarding the fundamentally different—and physiolog-
ically more relevant—characteristics of binding to surface-
bound ligand. In our previous work (Chesla et al., 1998), a
micropipette method was developed and used to measure
the two-dimensional (2D) kinetics of CD16a binding to total
serum IgG. In addition to the distinct membrane anchor,
CD16b differs from CD16a by six amino acids in the
extracellular domain. CD16b also possesses an even lower
affinity for soluble IgG than does CD16a (Chesla et al.,
2000). The major objective of this work was to use the
micropipette method to characterize the 2D kinetic rates and
equilibrium affinity of CD16b for the two most common
human IgG isotypes, IgG1 and IgG2, and to compare this
with the receptor’s interaction with soluble IgG.
To satisfy a parallel objective, the experiments were
designed so that the data gathered could be used to rigor-
ously test the validity of a new model for concurrent binding
of multiple species of receptors and ligands. This scenario
more closely approximates the in vivo situation, where cell
adhesion frequently involves simultaneous interactions of
several species of receptors and ligands. As such, the overall
adhesive outcome cannot be definitively attributed to any
particular species and may even involve bonds of multiple
species. However, given a large number of similar oppor-
tunities for adhesion, the concurrent binding model can be
used to probabilistically relate the observed adhesion fre-
quency to the average numbers of bonds of all species,
expressed in terms of their respective kinetic rates. The
model described in the previous companion paper (Zhu and
Williams, 2000) is completely general in the specification
of the receptor and ligand populations; that is, any number
of different receptors and ligands may be present. In this
paper and the next (Williams et al., 2000), two special cases
are examined for the dual purposes of validating the model
and gathering useful information on the kinetics of Fc
receptor binding. In this paper, data is presented from ex-
periments in which a single receptor, CD16b, was present




For radioimmunoassay (RIA), murine monoclonal antibody (mAb) CLB-
Fcgran1 (anti-CD16) was purified from hybridoma supernatant by protein
G affinity chromatography, cleaved into Fab fragments by Lampire (Pip-
ersville, PA), and iodinated in Iodogen-coated Eppendorf tubes. For flow
cytometry, supernatant of hybridoma-secreting CLBFcgran1 was used at
saturating dilutions without purification. GG7 (anti-human Fc mAb) was
obtained as ascites fluid from Sigma Chemical Company (St. Louis, MO).
FITC-conjugated polyclonal goat anti-mouse IgG (Sigma) was used as the
secondary antibody.
Lyophilized human IgG1 and IgG2 from myeloma plasma were ob-
tained from Sigma. After resuspension in unbuffered saline (1 mg/ml),
aliquots were stored at 4°C. Erythrocytes were isolated from whole blood
of normal healthy volunteers according to the following procedure. Ap-
proximately 7 ml whole blood was collected by venipuncture into sterile
Vacutainers (Becton Dickinson, San Jose, CA) containing EDTA. This was
carefully layered over 3 ml of Histopaque 1119 and centrifuged (30 min,
700  g, room temperature). The supernatant was removed and the
pelleted erythrocytes washed once in red blood cell (RBC) storage solution
(EAS45) (Dumaswala et al., 1996). RBCs were stored aseptically at 4°C in
EAS45/penicillin/streptomycin, at 20% hematocrit for up to three weeks
with negligible hemolysis.
Chinese hamster ovary cells (CHO-K1) transfected to express CD16b
(NA2 allotype), and nontransfected CHO-K1 cells, have been described
(Nagarajan et al., 1995). CHO cells were cultured in RPMI 1640 media
plus 10% fetal calf serum according to standard practices. Transfectant
CHO cell media were supplemented with 400 g/ml hygromycin as the
selection agent. CLBFcgran1 hybridoma cultures were weaned to 2% fetal
calf serum in OptiMEM (Gibco BRL, Grand Island, NY) or 5% Ultra-low
IgG FBS (Gibco) in RPMI prior to collection of supernatant. RPMI media
was supplemented with an additional 2 g/l glucose and 2 mM GlutaMax
(Gibco) (Nayve et al., 1994). Large-scale production of supernatant was
performed in sealed 2-liter roller bottles, and occasionally in large-capacity
T-flasks. When sealed bottles were used, the media was supplemented with
5 mM HEPES buffer (Reuveny et al., 1986). Initial cell density was chosen
based on the growth rate such that maximum densities would be reached in
six days or less.
Chromium chloride coupling of IgG to RBCs
Human IgG was covalently coupled to the membranes of RBCs by means
of a chromium chloride (CrCl3) method previously described (Chesla et al.,
1998). For mixed-isotype preparations, saline solutions of IgG1 and IgG2
(1 mg/ml) were combined in the desired ratio (2:1 or 1:2) prior to coupling.
Cells were subsequently washed and stored in EAS45. Aliquots (1 l) from
FIGURE 1 Structure of the human IgG isotypes 1 and 2. Isotypes of IgG
differ noticeably in the structure of their hinge regions, which connect the
two variable antigen-binding Fab fragments to the conserved effector-
stimulating Fc fragment. Additional disulfide bonds in the IgG2 hinge may
limit access to the C2 regions, which contain critical epitopes for Fc
receptor binding.
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each coupled sample were examined under light microscopy for excessive
aggregation. Samples were assayed for coating density and sample unifor-
mity by flow cytometry. In this assay the optimal ratios of protein to CrCl3
were determined empirically following a grid design. Although increasing
levels of CrCl3 consistently increased the coating levels, this also increased
the degree of cell aggregation. Increasing amounts of protein decreased
aggregation, but did not necessarily increase the coating densities. In fact,
excessive amounts of protein quenched the CrCl3 reaction completely.
This coupling method can provide very high coating densities and
involves a nonspecific reaction between the carboxyl groups on the soluble
protein and the RBC membrane proteins. It therefore is likely to result in
a spatially uniform and randomly oriented presentation of the bound IgG.
Coated RBCs remain quite flexible under micropipette manipulation and
are structurally similar to untreated RBCs upon examination by scanning
electron microscopy (Williams, 1998).
Site density determination
Site densities of IgG on RBCs were determined by quantitative indirect
fluorescent immunoassay (QIFI) (Poncelet and Carayon, 1985; Bikoue et
al., 1996; Serke et al., 1998) using an LFA-3 site density of 3900 mole-
cules/RBC as the reference standard (Selvaraj et al., 1987). Samples were
prepared for flow cytometry using the usual two-step staining protocol.
IgG-coated RBCs were incubated with anti-human Fc (GG7, 1:1000
ascites fluid), anti-LFA-3 (TS2/9 culture supernatant), or isotype-matched
negative control mAb (X63 culture supernatant) as first-step antibodies.
GG7 is highly reactive with all human IgG subclasses, and so total IgG
density was obtained. An Fc-specific FITC-conjugated goat anti-mouse
IgG (same lot) was used as the second-step reagent for all samples. The
median fluorescence (corrected for X63 nonspecific binding) relative to
LFA-3 was used to estimate site density of IgG.
The CD16b expression on the CHO cell transfectants was observed by
flow cytometry to be stable under the culture conditions described earlier.
Receptor site density was quantified by RIA using 125I-labeled anti-CD16
mAb. 125I-Fab CLBFcgran1 was incubated with cells at a saturating
concentration (2.4 g/ml). Triplicate samples were thoroughly washed and
counted, with the cell-bound radioactivity measured on a gamma counter.
Nontransfected cells were used as negative controls. Readings were con-
verted to site densities using specific activity of the 125I-mAb, determined
in parallel from standard samples (2 l aliquots of 125I-Fab). The mean
expression level was 9.3  105 per cell, or about 1600/m2, based on an
apparent surface area of 580 m2. With IgG coatings of 800–1000/m2,
this provided an excess of receptors and ligands relative to the anticipated
number of bonds, ensuring that the effects of competition would be
negligible (Zhu and Williams, 2000).
For the purposes of the analysis in this work, it was assumed that
receptors and ligands that were accessible by the antibodies described, and
therefore quantifiable by QIFI or RIA, were also available to each other in
the micropipette binding-frequency assay. An availability factor of less
than one would lead to an underestimation of AcKa and Ackf by this factor,
but would not affect the central comparative results presented in this paper
(Chesla et al., 1998).
Micropipette binding-frequency assay
The micropipette system and the binding-frequency assay have been de-
scribed in detail previously (Chesla et al., 1998). Briefly, narrow glass
pipettes (2–3 m inner diameter for RBCs, 5–8 m i.d. for CHO cells)
were prepared using a micropipette puller (Kopf, Tujunga, CA). Used RBC
pipettes were frequently stored for several weeks in capped RIA tubes
containing acetic acid, diluted 1:30 in de-ionized distilled H2O. Before use,
the storage solution was removed by displacement with a large-gauge
needle and backfilled with chamber solution by means of high suction.
Chamber solution was Hank’s Balanced Salt Solution with phenol red and
without calcium or magnesium, diluted to 45–55% with de-ionized dis-
tilled H2O, supplemented with 1% IgG-free BSA (Sigma) and sterile
filtered just prior to use. Chambers were mounted on a Zeiss inverted
microscope (Axiovert 100, Oberkochan, Germany) with an attached CCD
camera. Following introduction of cells to the chamber, one CHO cell and
one RBC were gently aspirated and aligned with a small axial gap between
them. Selected CHO cells were healthy and of a consistent, roughly
average, size. The RBC pipette was connected to a computer-controlled
piezoelectric actuator that was programmed to move its cell a fixed
distance at a uniform rate of 10 m/s. Cells remained in contact, allowing
zero-force kinetics to proceed for a prescribed duration, and then retracted.
An adhesion, indicating the presence of at least one bond at the moment of
retraction, was confirmed by the deflection of the RBC membrane. One
hundred contact cycles were conducted for each cell pair with multiple cell
pairs tested at each contact duration. Contact durations ranged from 1 to
16 s, which covered both the transient phase and the steady-state binding
of the interaction in question. Data in such a range are required to get good
estimates for both kinetic rates and equilibrium binding affinity. Adhesion
frequency was used as an estimate for the probability of an adhesion to be
present at the end of the contact time under the condition being tested.
Background-subtracted images were viewed in real time on a monitor and
stored on videotape for future analysis. In initial studies with this receptor–
ligand system, RBC aspiration pressures were tested over a range of 2–8
mm H2O (effectively tuning the RBC to different force-detection thresh-
olds) with no change in adhesion frequency, confirming that the measure-
ment accuracy was not limited by the ability to detect the weakest inter-
actions. The threshold of detection was below 2 pN, ensuring that
essentially no specific bonds would go undetected. At the other extreme of
forces, very strong bonds could lead to extraction of the proteins from the
membrane. However, the typical running frequency of adhesion was stable
over a hundred cycles, indicating that, if extraction of receptor or ligand
occurred at all, the surface densities of unbound protein were sufficiently
high to negate any impact on the binding kinetics.
Data analysis
Equilibrium affinity and kinetic rates were extracted from the binding
frequency data by iteratively reweighted nonlinear regression to the single-
species model (Chesla et al., 1998) or the concurrent binding model (Zhu
and Williams, 2000) using the Levenberg–Marquardt algorithm (Wolfram
Research, 1996). After analysis of the single-isotype data, prediction in-
tervals (with 95% confidence levels) were computed for the expected mean
response of the mixed-isotype experiments, assuming the validity of the
concurrent binding model. Details of the weighting method and the pre-
diction interval calculation are presented in the Appendix.
RESULTS
Binding to RBCs coated with single IgG isotypes
As shown in Fig. 2, for the interaction of the CD16b-
transfected CHO cells with RBCs coated with human IgG1,
a ligand coating density of 1000 IgG1/m2 resulted in a
binding frequency of about 50% at equilibrium. However,
RBCs coated with a similar density of IgG2 exhibited
equilibrium binding of only 22%. It is also apparent that the
binding of CD16b with IgG1 reached equilibrium faster
than with IgG2. Adhesions mediated by both IgG isotypes
were well above the 5% nonspecific binding of the same
CD16b-transfected CHO cells to RBCs coated with IgG-
free ovalbumin by means of the same chromium chloride
coupling procedure. Binding specificity for our CD16-ex-
1860 Williams et al.
Biophysical Journal 79(4) 1858–1866
pressing CHO cell/IgG-coated RBC system has been shown
previously by extensive control experiments (Chesla et al.,
1998, 2000; Williams et al., 2000).
Prior to analysis of the specific binding data, a smooth
curve was fit through the nonspecific data according to the
form
PN 1 expa1 e bt . (1)
This function has two free parameters, rises from 0 at t 	 0
and asymptotically approaches an equilibrium level of 1 
ea as t3 
. This is identical to the structure of the specific
binding (compare with Eq. 2 below), though here we have
made no efforts toward physical interpretation of the pa-
rameters a (	 0.05) and b (	 0.3 s1). The quality of the fit
to the ovalbumin data in Fig. 2 supports the use of this
function.
Analysis of the single isotype data proceeded by remov-
ing the smoothed nonspecific component estimated from
Eq. 1 from each observed total binding probability; that is,
PS 	 (PT  PN)/(1  PN) where subscripts denote specific,
nonspecific, and total adhesions, assuming specific and
nonspecific binding to be independent rather than mutually
exclusive events (Zhu and Williams, 2000). Fitting the
resulting data, along with the known predictor variables
(receptor and ligand surface densities mr and m, contact
duration t) to the single-species binding model (Chesla et
al., 1998),
PS 1 expmr m AcKa1 exp kr t , (2)
yielded estimates for the regression parameters AcKa (the
2D binding affinity scaled by the constant but unknown
contact area Ac) and kr (the reverse rate constant). The
forward 2D rate constant (scaled by Ac) Ac kf was calculated
from the relationship Ka 	 kf/kr. The IgG1-only and the
IgG2-only data were separately regressed to this model and
the derived estimates for the binding constants and their
standard errors are listed in Table 1. The solid lines shown
on Fig. 2 represent the associated best-fit curves. It is
evident that the agreement between the data and the fitted
curves is quite good, providing further support for the
single-species kinetic model of Chesla et al. (1998).
Prediction intervals for the mean
mixed-isotype response
Using the data obtained from the single-isotype experi-
ments, we wanted to make predictions about the adhesion
probability for mixed-isotype experiments, based on the
concurrent binding model. Following the methods described
in the Appendix, prediction intervals (with 95% confidence
levels) for the mean response under concurrent binding
were calculated. The calculation used, as input, two sets of
binding affinities and reverse rates (and their associated
covariance matrix) determined from the single-isotype ex-
periments and ligand densities m1 (for IgG1) and m2 (for
IgG2) matching those of the mixed-isotype experiments.
The two prediction intervals are shown in Fig. 3 (paired
curves).
It should be noted that prediction intervals for the mean
response provide insight into the distribution of the ex-
pected means, not the distribution of the expected data,
which is generally much broader. Mean response prediction
intervals continually narrow as the amount of incorporated
data increases, whereas prediction intervals for the data
distribution approach a finite spread reflecting the charac-
teristic variation of the system elements. Because of this
dependence on the data set size, the prediction intervals
generated from the single-isotype data were compared to
mean responses obtained from a similar quantity of dual-
isotype data.
FIGURE 2 Single-isotype binding curves. CD16b-expressing CHO cells
were held in contact with RBCs coated with human IgG1 ({) at 1000
molecules/m2, IgG2 (F) at 980 molecules/m2, or IgG-free ovalbumin
(‚). Each point represents total adhesion probability estimated from one
cell pair with 100 cycles of contact. IgG curves were calculated according
to PT 	 PN  PS  PNPS, where PN and PS are given by Eqs. 1 and 2,
respectively, based on the best-fit parameters (Zhu and Williams, 2000).
TABLE 1 Summary of binding parameters for CD16bNA2
Ligand Coating
AcKa (10
7 m4) kr (s
1)
IgG1 IgG2 IgG1 IgG2
IgG1 only 3.8  0.2 — 0.64  0.11 —
IgG2 only — 1.3  0.2 — 0.29  0.10
Mixed isotypes only 4.4  0.4 1.6  0.5 0.84  0.20 0.10  0.21
All data 4.0  0.2 1.4  0.2 0.70  0.11 0.28  0.10
n 	 10, 8, 20, and 38 cell pairs (100 contact cycles each), respectively, for
each ligand-coating set above. An additional 10 cell pairs were used to
characterize the nonspecific binding.
Values are mean  SE.
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Binding to RBCs coated with mixed IgG isotypes
Mixed-isotype coatings were prepared with a ratio of IgG1
to IgG2 of either 2:1 or 1:2. As shown in Fig. 3, both
samples displayed binding time courses between the two
single-isotype data (Fig. 2), with the binding of the 2:1 ratio
sample somewhat more frequent than that of the 1:2 ratio
sample. For comparable total densities of IgG, this sequen-
tial laddering of the data from low to high as IgG1 content
increases and IgG2 content decreases is consistent with an
equilibrium binding affinity of CD16b for IgG1 substan-
tially higher than that for IgG2, as suggested by the soluble
binding assays. It was an important consideration in our
experimental design to use two IgG isotypes with substan-
tially different kinetic rates and binding affinities to CD16b.
Similar binding constants for the two ligand species would
have led to similar time courses for the adhesion probability
regardless of the mixing ratios. Although the assay would
have still yielded kinetic data, it would not have provided an
adequately rigorous test of the concurrent binding model,
because this model would have collapsed to the single-
species form, leaving the multi-species extension com-
pletely unexplored.
The two sets of mixed-isotype data in Fig. 3 were fit
simultaneously to the concurrent binding model (Zhu and
Williams, 2000),
PS 1 exp n1 n2 , (3a)
where
ni mrmiAcKai1 exp krit (3b)
may be interpreted as the average number of bonds per
contact that is mediated by the ith IgG isotype. The specific
binding probability data were determined by removal of the
smoothed nonspecific data from the total binding observed,
as was done in the single-isotype analysis discussed above.
Use of the multispecies version of the concurrent binding
model involves the simultaneous determination of affinity
and reverse rate constants for all ligands present, IgG1 and
IgG2 in this case. The values and standard errors for the four
binding constants obtained in this manner are listed in Table
1. The best-fit curves associated with these parameters (Fig.
3) represent estimates of the mean behavior for the mixed-
isotype binding conditions. The best-fit concurrent binding
curves generated from the dual-isotype data fall within the
prediction intervals generated from the single-isotype data
at virtually all times.
Best estimates for the binding constants
The kinetic rate and binding affinity constants describing
the interaction of CD16b and the human IgG isotypes 1 and
2 were independently estimated from the single-species data
and the dual-species data. The ability for the binding con-
stants derived from the single-species data to successfully
predict the mixed IgG isotype experiments (Fig. 3) suggests
that their values agree with the corresponding parameters
estimated from the dual-species data. This is indeed the case
(Table 1). Through the use of the concurrent binding model,
it was also possible to incorporate the entire data set (48 cell
pairs, including 10 lacking IgG) into a single best estimate
of these parameters. Results from this analysis are also
listed in Table 1.
DISCUSSION
A new sensitivity level demonstrated for the
micropipette method
A major goal of the present work was to measure the 2D
kinetic rate and binding affinity constants of the low affinity
Fc receptor CD16b for the two most abundant IgG sub-
types. In previous publications, the three-dimensional (3D)
affinity of CD16b for soluble IgG2 has been stated as being
extremely low (Powell et al., 1996) or nonexistent (Huiz-
inga et al., 1989; Sautes, 1997). Therefore, it was expected
to represent a challenge to our recently developed micropi-
pette method. However, with sufficiently high densities of
receptor and ligand, we were able to quantify both the
affinity and kinetic rates with good resolution. Still, the
FIGURE 3 Dual-isotype binding curves. CD16b-expressing CHO cells
were held in contact with RBCs coated with ratios of IgG1:IgG2 of 2:1 (E)
or 1:2 (}). Total IgG content was 890 and 780 molecules/m2, respec-
tively. Solid curves represent the weighted least-squares fits of all dual-
species data to the concurrent binding model. Gray regions represent the
95% prediction intervals for the means obtained from inserting the single-
species results into the concurrent binding model. Nonspecific binding was
included in these PT curves in the same manner as the single-isotype
analysis (cf. Fig. 2 legend). Each point represents one cell pair with 100
cycles of contact.
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weakness of this interaction is illustrated by the fact that,
even with the highest protein densities examined (1600
CD16b and 980 IgG2 per m2 in the IgG2-only case),
specific adhesions were present at the end of only about
20% of the long-duration contacts (Fig. 2). The sensitivity
of the 2D binding-frequency assay was demonstrated at a
new level. The 2D equilibrium affinity of this receptor–
ligand pair (AcKa 	 1.4  10
7 m4) is the lowest of any
previously reported affinities (Chesla et al., 1998, 2000).
The average number of bonds per adhesion can be cal-
culated by dividing the average number of bonds per con-
tact, n, by the probability of specific adhesion, PS. From
Eq. 2, we see that this number was only about 1.1 for the
above CD16b–IgG2 interaction. A caveat to the above cal-
culation is that the micropipette-aspirated RBC adhesion
detector must be sufficiently sensitive to ensure that no
specific bonds would go undetected. This was investigated
experimentally by measuring the dependence (or the lack
thereof) of the detectable adhesion frequency on the RBC
aspiration pressure. The tested range was 2–8 mm H2O,
corresponding to force detection thresholds from 2 pN to
10 pN. No changes in the measured adhesion frequency
were found, confirming that the measurement accuracy was
not limited by the sensitivity cutoff.
Validation of the concurrent binding model
A parallel goal of this paper was to test the model of
concurrent binding of multiple molecular species developed
in the companion paper (Zhu and Williams, 2000). A fre-
quently used (although weak) test for the validity of a model
is how well it fits experimental data. Here, a more challeng-
ing test was also devised, namely, how accurate the model
predicts results from new experiments, using a priori knowl-
edge obtained independently. Our approach was to divide
the data into two groups—one that could be analyzed using
an existing model and the other that would require the use
of the extended model. Applying the existing single-species
model to the first data group, kinetic rates were obtained
describing how CD16b interacted with two human IgG
isotypes individually when each was presented as a homo-
geneous population (Fig. 2). Next, this information was
used as input to the extended dual-species model to predict
how the receptor might interact simultaneously with the two
ligands when both were presented as heterogeneous popu-
lations. The prediction was then compared to the actual data
in the second group obtained from experiments with dual-
isotypes mixed at two different ratios (Fig. 3). The excellent
correspondence found in this comparison has thus provided
substantial support for the probabilistic kinetics arguments
upon which both the original single-species model and the
new multi-species model rely.
Estimating the binding characteristics of CD16b
to total serum IgG
In this study, the two predominant isotypes of human IgG
have been treated as unique ligands. The substantial differ-
ence in their associated binding constants warrants this
treatment. What then does this mean for interpretation of
published FcR kinetics experiments in which total human
serum IgG is treated as a single ligand? In these cases, the
binding constants determined are for an imaginary homog-
enized ligand, bearing characteristics that are a blend of
those of the individual isotypes actually present (Zhu and
Williams, 2000). In this work, for example, if we study the
cells prepared from a 2:1 ratio of IgG1:IgG2 as if they
expressed a single homogeneous ligand, then analysis of the
data (using the single-species rather than the concurrent
model) gives an affinity of 3.3  107 m4 and a reverse
kinetic rate of 0.56 s1. Comparison with the values for the
individual component isotypes in Table 1 illustrates the
effects of homogenization. We also note that the 2:1 sample
reasonably approximates total serum IgG, and so the values
above represent an estimate for the binding parameters
expected from similar experiments using total serum IgG-
coated RBCs with the CD16b-expressing CHO cells.
Binding to membrane-bound ligands differs
substantially from binding to the soluble forms
Although the affinity of CD16 for IgG has been measured in
solution in some cases, for CD16-expressing leukocytes, it
is affinity to immobilized antibody, bound to pathogens or
damaged tissue, that is critical. This study represents the
first measurements of CD16b affinities for immobilized
IgG1 and IgG2. Our results show that the 2D equilibrium
affinity of CD16b for IgG1 is about three times that for
IgG2. Although this is a significant shortcoming, it should
not prevent IgG2, immobilized to surfaces and in sufficient
density, from participating in the stimulation of effector
responses in CD16b-expressing neutrophils. The difference
in the forward kinetic rate, however, is more dramatic. The
reverse rate of IgG1 is about twice that of IgG2, so, from
Ka 	 kf /kr, it is apparent that the forward rate of IgG1 must
be about six times that of IgG2. The ability to form adhe-
sions during very brief contacts in circulation ought to be a
critical skill for cells of the immune system, in particular Fc
receptor-bearing cells. From its low forward rate constant, it
is apparent that IgG2 does a poor job of initiating such
adhesions, but its low reverse rate suggests that it retains
bonds longer than IgG1. This may indicate a more signifi-
cant role for IgG2 in longer duration adhesions (5 s) than
in transient contacts. Figure 4 illustrates how the IgG2 to
IgG1 bond ratio grows from less than 15% at the beginning
of the contact to more than a third in equilibrium given
equal densities of membrane-bound IgG1 and IgG2.
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It is surprising that the seemingly large relative 3D affin-
ity of CD16b for IgG1 and IgG2 (IgG2 Ka
3D  0) only
translates into a mere threefold difference in 2D affinity.
However, this is not an isolated case. The 2D affinity for
total human IgG of CD16bNA2 (estimated in the preceding
section using 2:1 IgG1:IgG2 data) is, respectively, about a
half and a sixth of those of CD16a and CD16a-GPI, a
chimeric molecule created by replacing the polypeptide
transmembrane anchor of CD16a with the GPI anchor of
CD16b (Chesla et al., 2000). By comparison, the 3D affinity
of CD16bNA2, measured by competitive inhibition using
soluble total human IgG, is about a tenth and a hundredth of
those of CD16a and CD16a-GPI, respectively (Chesla et al.,
2000). This tremendous compression of the relative affini-
ties in the 2D case demonstrates the distinctly different
character of adhesion between membrane-bound molecules
and the 3D soluble case. The underlying cause of this
compression is a matter of current research and will require
an understanding of both the protein conformation and its
presentation by the membrane. This represents a challenge
to the existing theory of 3D-to-2D affinity conversion (Bell,
1978; Bell et al., 1984; Kuo and Lauffenburger, 1993;
Lauffenburger and Linderman, 1993; Dustin et al., 1996);
and it emphasizes the need to measure 2D binding param-
eters directly.
APPENDIX
Most of the results of this paper are derived from nonlinear regression
analysis of micropipette data. For completeness, the specific details of the
approach used in this work are presented below.
Iteratively reweighted least-squares method
The weighted least-squares problem for model y 	 f (x, b) is to determine
the fit parameters b by minimizing the weighted squared residuals 2 from












wj yj fxj, b2 . (A1)
For the concurrent binding model (Eq. 3), the specific adhesion frequency
PS is the observed response (PT may be used if specific and nonspecific
binding are being regressed simultaneously), surface protein densities and
contact time are the predictor variables, and affinities and reverse rates are
the fit parameters. The N weights wj are chosen to minimize heteroscedas-
ticity. (The wj  1 case is ordinary least-squares.)
Ordinary least-squares regression assumes that residuals are normally
distributed about the best fit and that the variances of their distributions are
equal for all the conditions examined. Heterogeneity of variance, or het-
eroscedasticity, will result in an inappropriate best fit and an inaccurate
estimate of the standard errors of the regression parameters (Carroll and
Ruppert, 1988). Figure 5 shows residuals from micropipette binding fre-
quency experiments, illustrating the dependence of the variance of P on the
response P. (Correlation between  P
2 and all predictor variables is also
present, but not shown.) A weighting function was used to reduce the
excessive heteroscedasticity in the data.
Choice of weighting function
The weights were chosen to be proportional to the inverse variances; that
is, wj	 c/ j
2. The constant c has no effect on the fit, as can readily be seen
from Eq. A1. The true variances  j
2 of the residual distributions are
unknown and estimates of their relative magnitudes must be made. We
chose to use several physical assumptions (described below) to develop a
function for  P
2, and required that it display heteroscedasticity consistent
with the residual data in Fig. 5.
FIGURE 4 Relative participation of IgG2 in bond formation. When a
CD16b-expressing cell encounters a surface with equal amounts of immo-
bilized IgG1 and IgG2, almost all bond formation in the initial seconds of
contact are mediated by IgG1. However, if contacts are maintained beyond
five seconds, the relative participation of IgG2 will double due to its slower
reverse rate.
FIGURE 5 Dependence of residuals on adhesion probability P. The
absolute values of the residuals following regression of the micropipette
data shows considerable heteroscedasticity. The final weighting function
(square root of Eq. A2) is shown, determined from the indicated best
estimates for the free parameters o and . The expected probabilities are
shown on a log scale to improve visualization of data below 10%.
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Our micropipette assay estimates the adhesion probability P from re-
peated tests of individual cell pairs. The site densities, mr and m, of the
receptors and ligands may be broadly distributed in cell populations.
However, only the population means, not the variances, are accounted for
in the models (Eqs. 2 and 3). Therefore, it seems reasonable to assume that
the variance of P,  P
2, is primarily due to the cell-to-cell variations in mr
and m. Because mr and m are being considered here as random variables,
it follows that the product mrm is also a random variable. It can be
estimated from Eq. 2 that
 P




2 1 P)ln1 Pmrm 
2
.
Further assuming that the standard deviation of mrm, mrm, is propor-




2  21 Pln1 P2 ,
where  is the coefficient of variation for mrm. (ˆ represents an estimator
of the quantity under the caret.) This function has a maximum at P 	 0.63,
but diminishes to zero as P3 0. There is in practice, however, a nonzero
minimum variance that incorporates other less significant variance sources.
For example, we estimate P from a hundred observations; hence P has a
resolution no better than 0.5%. To accommodate these other sources, we




 21 P)ln1 P2 . (A2)
Estimates for the two variance parameters, o and , can be found by
ordinary nonlinear regression of Eq. A2 to the squared residuals. However,
to minimize the influence of outliers, it was found to be more appropriate
to fit the square root of the variance model (the standard deviation model)
to the absolute value of the residuals (Fig. 5).
Because, with this approach, the estimated variances (and therefore the
weights) depend on the expected response P itself, the solution to the
problem becomes an iterative one. First, an initial estimate for b (i.e.,
kinetic rate and binding affinity constants) was found by unweighted
(ordinary) least-squares. The estimated responses Pˆj (	 f (xj, bˆ)) and the
absolute residuals were used to compute the variance parameters o and .
A set of weights was then derived (from wj 	 c/ˆ P
2(Pˆj)) and a weighted
least-squares regression was performed to estimate a new b. At least three
cycles were executed to reach convergence (Carroll and Ruppert, 1988,
Chapter 2; Neter et al., 1996, Chapter 10).
The final standard deviation model (ˆP versus P curve) is shown
superimposed over the residuals in Fig. 5. Note that tight variances are
expected when adhesion probability is very low or very high, hence the
resolution of the assay is maximal with midrange frequency data. A plot of
the absolute weighted residuals, wjj, against the expected response P
confirmed the reduction in heteroscedasticity (not shown). For all micropi-
pette data analyzed in this manner,  ranged between 12 and 16% and o
ranged between 0.5 and 2%. The relatively low value for  indicated
acceptable uniformity in the expression level of CD16b on the transfectants
and in the IgG coating density on the RBCs.
Normal distribution of residuals
The normality of the distribution of the weighted residuals was verified by
ordering the N residuals from low to high, computing the expected normal
value for the jth residual, and plotting the results against the actual
residuals (a normal probability plot, not shown). The linear diagonal
pattern indicated that the residuals were approximately normally distrib-
uted and so the requirements of least-squares regression were met without
further adjustments (Neter et al., 1996, Chapter 3).
Nonlinear prediction intervals on the mean
Once an iteratively reweighted, nonlinear least-squares problem converges,
we have estimates for the M-dimensional vector of regression parameters
b  bˆ and can compute the M  M asymptotic covariance matrix  from




where dfj/db is an N  M matrix of derivatives of the model function yj 	
f (xj, b) (the single-species model, Eq. 2), with the jth row evaluated at xj.
W is an N  N diagonal matrix of weights wj, and c is the proportionality
constant relating the weights to the true residual variances, as discussed
earlier (Jennrich, 1995, Chapter 8; Neter et al., 1996, Chapter 10).
The resulting fit parameters and their covariance matrices can be used
to establish prediction intervals for the mean response to mixed-isotype
conditions. Let g(z, b) be a nonlinear function of the fit parameters b and
predictor variables z. Here g is the dual-species concurrent binding model
(Eq. 3). We wish to predict the mean response g and the confidence interval
for the mean response at z 	 zo from a predetermined bˆ with covariance
. (This is more restrictive than the confidence interval on the response,
which would describe the distribution of all responses at z 	 zo.) This is
usually referred to as a prediction interval on the mean, and is given by
(Carroll and Ruppert, 1988, Chapter 2; Jennrich, 1995, Chapter 8)
mean response  (1  )% confidence interval
 gzo, bˆ t NM
1/2 dgdb  dgTdb 
zo,bˆ
, (A3)
where  is chosen to be 0.05 for prediction intervals with 95% confidence
levels. Here g is different from the single-species model f (Eq. 2) used to
generate bi and i for each single species. The five-dimensional vector z
(	 {mr1, m1, mr2, m2, t}
T) is evaluated at zo, which generally takes
component values different from those of the two 3D predictor variable
vectors, xi 	 {mri, mi, t}
T (i 	 1, 2). The vector dg/db is developed from
the four-dimensional fit-parameter vector b (	 [b1
T, b2
T]T 	 {AcKa1, kr1,
AcKa2, kr2}
T) and is then evaluated at b 	 bˆ, the component values of
which have previously been determined from the two single-isotype re-
gressions. The 4 4 covariance matrix  is similarly constructed from the
two single-isotype 2  2 covariance matrices, 1 and 2, according to
 1 00 2 .
Thus, the location of the mean response and the width of the its confidence
interval (Eq. A3) for a given dual-species condition zo are determined by
the fitted single-species binding parameters and their variability, estimated
a priori from completely independent experiments and model functions.
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